About Renocrit 4000 IU
- Product Name: Renocrit 4000 IU Injection
- Composition: Recombinant Human Erythropoietin 4000 IU
- Form: Injectable solution
- Type: Prescription-only
- Packaging: Vial
- Manufacturer: Zydus
- Use: Supports anemia management in CKD and related conditions
Introducing the new Erypro Safe Recombinant Human Erythropoietin Injection IP 4000 IU, a hot-selling solution crafted for unprecedented efficacy in treating anemia linked to chronic renal failure and chemotherapy. Manufactured by Biocon, this superlative biological injection harnesses the crowning formulation of Recombinant Human Erythropoietin Alfa. Delivered in a preservative-free, clear colorless liquid via subcutaneous or intravenous routes, it stimulates red blood cell production with remarkable safety. Competitive pricing and uncompromised quality make Erypro Safe an unrivaled choice for healthcare providers across India. Available in a robust, prefilled syringe.
Site of Application and Usage Method
Recombinant Human Erythropoietin Injection IP 4000 IU is administered subcutaneously or intravenously, ensuring optimal delivery directly into the bloodstream. The site of application is typically the upper arm, thigh, or abdominal area for subcutaneous use, or a suitable vein for intravenous use. Type of usage is strictly as prescribed, offering a targeted approach to managing anemia in adults and pediatric patients, thereby maximizing therapeutic benefit and patient comfort through precise administration.
Sample Availability, Supply Ability, and FOB Port
We proudly offer samples of Recombinant Human Erythropoietin Injection IP 4000 IU, ensuring customers experience market-leading efficacy at the lowest price. With strong supply ability, we meet bulk demands efficiently while maintaining superior packaging standards-one prefilled syringe per box preserves product integrity. Enjoy direct shipment from leading Indian FOB ports, maximizing market value and client convenience for traders, suppliers, and healthcare institutions throughout India and beyond.
FAQ's of Recombinant Human Erthropoietin Injection IP 4000 IU:
Q: How should Recombinant Human Erythropoietin Injection IP 4000 IU be administered?
A: This injection is administered either subcutaneously (beneath the skin) or intravenously (into a vein), as directed by a registered medical practitioner. It is crucial to follow the physician's instructions regarding dosage and frequency.
Q: What are the main therapeutic benefits of this injection?
A: The primary benefit of this injection is to stimulate red blood cell production, making it especially effective in treating anemia linked with chronic renal failure, chemotherapy, and HIV therapy.
Q: When is it recommended to use this medication?
A: This medication is recommended for patients suffering from anemia due to chronic kidney disease, chemotherapy, or HIV therapy, based on a medical practitioner's evaluation and prescription.
Q: Where should this injection be stored to maintain its effectiveness?
A: Store the prefilled syringe at a temperature between 2C and 8C. Do not freeze the product, and keep it away from direct light to maintain its effectiveness throughout its 24-month shelf life.
Q: What precautions should be considered before using this medication?
A: This medication must only be used under strict medical supervision. Inform your doctor about any history of hypertension or allergic reactions. Be aware of possible side effects such as high blood pressure, headache, joint pain, and allergic responses.
Q: How can I obtain a sample or place a bulk order?
A: Samples are available upon request, and bulk orders can be arranged through leading Indian FOB ports, ensuring efficient supply and competitive pricing to accommodate various market needs.